APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma
Clinical trial NCT03502330 · COMPLETED
Trial details
- NCT number
- NCT03502330
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-09
- Primary completion
- 2022-01-05
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.